First Affiliated Hospital of University of South China
In research, First Affiliated Hospital of University of South China stands highest in Life Sciences (#1,908 of 7,800 worldwide), Medicine (#3,483 of 10,443 worldwide) and Health Sciences (#4,584 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Cancer Research and Immunology and Microbiology — Cancer Research is 14.9× its share of world research.
- World rank, 2022–2025
- #4,778 of 28,054 · #10,123 all time
- Rank in China
- #1,065 of 3,058
- Research works
- 1.2k ▲ 50% vs 2013–17
- Citations
- 16k 13.1 per fractional work
- Top-10% rate
- 29.1% record average 16.5%
- Open access
- 40% world 28%
What is First Affiliated Hospital of University of South China known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #1,908 of 7,800 | 29.0% | 138 | #4137 | |
| MedicineField | #3,483 of 10,443 | 28.5% | 167 | #6787 | |
| Health SciencesDomain | #4,584 of 11,982 | 28.9% | 174 | #8636 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,686 of 3,579 | 30.1% | 98 | #3629 |
Each strip is that field’s whole ranked pool, with the notch where First Affiliated Hospital of University of South China sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#4,137 #1,908
- Medicine#6,787 #3,483
- Health Sciences#8,636 #4,584
- Biochemistry, Genetics and Molecular Biology#3,629 #1,686
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does First Affiliated Hospital of University of South China specialise in?
Where its research is concentrated relative to its size: Cancer Research takes 14.9× the share of its output that it takes of world research.
- Cancer ResearchSubfield · 22.1 works15×
- Immunology and MicrobiologyField · 20.2 works5.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.9×. Every wedge is a field page.
- Immunology and Microbiology 5.9×
- Biochemistry, Genetics and Molecular Biology 5.4×
- Pharmacology, Toxicology and Pharmaceutics 2.9×
- Medicine 2.5×
- Neuroscience 2.5×
- Nursing 1.9×
- Chemistry 0.5×
- Dentistry 0.4×
- Materials Science 0.4×
- Health Professions 0.3×
- Energy 0.2×
- Engineering 0.2×
- Physics and Astronomy 0.2×
- Computer Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Decision Sciences 0.1×
- Psychology 0.1×
- Mathematics 0.1×
- Chemical Engineering 0.1×
- Environmental Science 0.1×
- Social Sciences 0.0×
Which keywords describe research at First Affiliated Hospital of University of South China?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Oxidative Stress, Gene Expression, Tumor Microenvironment, Biogenesis, Cell Death and Regulation.
- Dysregulation
- Gene Expression Regulation
- Therapeutics
- MicroRNA Sponges
- Atherosclerosis
- RNA Regulation
- Cancer Biomarkers
- Cellular Functions
- GPX4
- Clinical Practice Guidelines
- Innate Immunity
- Apoptosis
- Immunity
- Epigenetic Regulation
- Metabolism
- Biomarkers
- Cell Death
- Tumor Microenvironment
- Gene Expression
- Inflammation
- Cancer
- Oxidative Stress
- Epidemiology
- Biogenesis
- Regulation
- Cardiovascular Disease
- Metastasis
- Disease
- Cancer Progression
- Reactive Oxygen Species
- Lipid Peroxidation
- Ferroptosis
- Angiogenesis
- Cell Differentiation
- Long Noncoding RNAs
- Translation
- Circular RNAs
- Cytokines
- Mitochondria
- MicroRNA
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer54▲ 12×41 topics
- Inflammation50▲ 7.0×79 topics
- Oxidative Stress30▲ 5.5×49 topics
- Gene Expression20▲ 9.6×14 topics
- Epidemiology20▲ 1.45×76 topics
- Tumor Microenvironment19▲ 13×8 topics
- Biogenesis17▲ 28×3 topics
- Cell Death16▲ 21×6 topics
- Regulation16▲ 8.8×11 topics
- Biomarkers16▲ 6.7×14 topics
- Cardiovascular Disease14▲ 3.7×32 topics
- Metabolism12▲ 6.8×22 topics
- Metastasis12▲ 10×11 topics
- Epigenetic Regulation11▲ 15×5 topics
- Disease10▲ 34×3 topics
- Immunity10▲ 7.5×9 topics
- Cancer Progression10▲ 15×8 topics
- Apoptosis10▲ 9.2×15 topics
- Reactive Oxygen Species9▲ 6.7×13 topics
- Innate Immunity9▲ 8.2×11 topics
- Lipid Peroxidation9▲ 24×2 topics
- Clinical Practice Guidelines8▲ 4.6×14 topics
- Ferroptosis8▲ 32×1 topic
- GPX48▲ 32×1 topic
- Angiogenesis8▲ 7.5×15 topics
- Cellular Functions8▲ 32×3 topics
- Cell Differentiation8▲ 25×2 topics
- Cancer Biomarkers8▲ 28×3 topics
- Long Noncoding RNAs8▲ 27×1 topic
- RNA Regulation8▲ 22×1 topic
- Translation8▲ 13×2 topics
- Atherosclerosis7▲ 7.5×11 topics
- Circular RNAs7▲ 51×1 topic
- MicroRNA Sponges7▲ 51×1 topic
- Cytokines7▲ 7.2×8 topics
- Therapeutics7▲ 18×2 topics
- Mitochondria7▲ 15×4 topics
- Gene Expression Regulation6▲ 18×3 topics
- MicroRNA6▲ 16×2 topics
- Dysregulation6▲ 25×1 topic
Which research topics does First Affiliated Hospital of University of South China publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Cancer-related molecular mechanisms research, Circular RNAs in diseases and MicroRNA in disease regulation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 8 works
- 2 Cancer-related molecular mechanisms research Cancer Research 8 works
- 3 Circular RNAs in diseases Molecular Biology 7 works
- 4 MicroRNA in disease regulation Cancer Research 6 works
- 5 RNA modifications and cancer Molecular Biology 6 works
- 6 Inflammasome and immune disorders Molecular Biology 4 works
- 7 Immune cells in cancer Immunology 4 works
- 8 Cancer, Hypoxia, and Metabolism Cancer Research 4 works
- 9 Extracellular vesicles in disease Molecular Biology 4 works
- 10 Autophagy in Disease and Therapy Epidemiology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has First Affiliated Hospital of University of South China's research output changed?
Output in 2018–2022 was 50% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hengyang
- University of South China
- Hengyang Normal University
- Hunan Institute of Technology
- Hengyang Academy of Agricultural Sciences
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.